Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The ...

HxM™ BT Solution Advantage The HxM™ BT Solution takes personal fitness monitoring to a new level. Real-time feedback including heart rate, speed and distance measures, combined with a focus on ...

The UK public body has urged the use of the Manchester developed TriageHF Plus after research found it cut hospitalisations ...

Warren Mauston, a heart patient at St. Paul’s Bethesda Hospital, would become the first U.S. patient to be fitted with an ...

Medical technology giant Medtronic will purchase miniaturised heart device firm ... systems and battery technologies, patient monitoring, manufacturing, global regulatory policy and ...

After research by Rudy, Ramanathan, Jia and others was published in Nature Medicine in 2004, The New York Times had this story headline about the advance: "What's Next; Beyond the EKG, to a ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Renee Wegrzyn, director of the Advanced Research Projects Agency for Health, is calling on the private investment community ...

A new device to prop open heart arteries after interventions to ... in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now. The stock has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...